ketoconazole has been researched along with n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Doss, GA; Karanam, BV; Kumar, S; Lanza, TJ; Lin, LS; Raab, CE; Reddy, VB; Samuel, K; Stearns, RA; Yu, NX; Zhang, AS | 1 |
1 other study(ies) available for ketoconazole and n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide
Article | Year |
---|---|
In vitro and in vivo metabolism of a novel cannabinoid-1 receptor inverse agonist, taranabant, in rats and monkeys.
Topics: Amides; Animals; Antibodies, Monoclonal; Body Fluids; Brain; Drug Inverse Agonism; Female; Haplorhini; Humans; Ketoconazole; Magnetic Resonance Spectroscopy; Male; Mass Spectrometry; Microsomes, Liver; Pyridines; Radioactivity; Rats; Receptor, Cannabinoid, CB1 | 2010 |